Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

ITOS holding history

iTeos Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITOS overviewAll 13F holders of ITOSFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ITOS by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−429,340−100.0%Sold outHolders
Q2 2025429,340$4.28M<0.1%+178,209+71.0%AddedHolders
Q1 2025251,131$1.50M<0.1%+514+0.2%AddedHolders
Q4 2024250,617$1.92M<0.1%−250,749−50.0%ReducedHolders
Q3 2024501,366$5.12M<0.1%−587,933−54.0%ReducedHolders
Q2 20241,089,299$16.2M<0.1%−543,057−33.3%ReducedHolders
Q1 20241,632,356$22.3M<0.1%+500,863+44.3%AddedHolders
Q4 20231,131,493$12.4M<0.1%+869,740+332.3%AddedHolders
Q3 2023261,753$2.87M<0.1%+85,073+48.2%AddedHolders
Q2 2023176,680$2.34M<0.1%−386,534−68.6%ReducedHolders
Q1 2023563,214$7.67M<0.1%−283,645−33.5%ReducedHolders
Q4 2022846,859$16.5M<0.1%+12,965+1.6%AddedHolders
Q3 2022833,894$15.9M<0.1%−219,340−20.8%ReducedHolders
Q2 20221,053,234$21.7M<0.1%+250,864+31.3%AddedHolders
Q1 2022802,370$25.8M<0.1%+638,371+389.3%AddedHolders
Q4 2021163,999$7.64M<0.1%+7,391+4.7%AddedHolders
Q3 2021156,608$4.23M<0.1%+65,256+71.4%AddedHolders
Q2 202191,352$2.34M<0.1%+91,206+62,469.9%AddedHolders
Q1 2021146$5.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.